The increasing reliance on software and connectivity in medical devices has made cybersecurity a key aspect of patient safety, product quality, regulatory compliance, and market access. However, many organizations still employ a fragmented approach to managing cybersecurity, using disparate tools, teams, and documentation, which can hinder their ability to respond swiftly to emerging vulnerabilities. As a result, cybersecurity can no longer be viewed as a secondary consideration, but rather as an integral part of the development process. MedTech manufacturers must adopt a full lifecycle approach that integrates cybersecurity requirements, risks, verification, software composition, releases, and post-market vulnerabilities from the outset.
Integrating Security into the Engineering Process
By treating cybersecurity as an engineering responsibility, organizations can proactively identify and address vulnerabilities, reducing the risk of product risks and post-market remediation efforts. To achieve this, security requirements must be established early on and linked to identified threats and risks, design decisions, verification activities, and release baselines. Maintaining these relationships throughout development enables teams to detect gaps and inconsistencies earlier, preventing validation issues, submission delays, and post-market risks. This approach also provides a stronger foundation for demonstrating the implementation and verification of cybersecurity requirements, rather than assembling evidence retrospectively.
In today’s fast-paced development cycles, traditional documentation methods often struggle to keep pace. By incorporating security requirements into the engineering process from the start, teams can resolve issues at the source, reducing the need for rework and minimizing compliance gaps. This proactive approach enables organizations to prioritize cybersecurity, ensuring that it is not treated as an afterthought, but rather as an integral part of the product development process.
Read Also: Tessaly Network Applies FDA Plan to Rebuild AI
Establishing End-to-End Traceability
As software complexity increases, organizations must be able to answer a fundamental question: what is the impact of a change on the entire product ecosystem? A newly discovered vulnerability, software update, requirement change, or component change can have far-reaching consequences, affecting multiple product versions, tests, controls, and releases. By connecting cybersecurity artifacts across the lifecycle, teams can gain visibility into these dependencies, enabling them to understand the relationships between threats, risks, requirements, verification, releases, and vulnerabilities. This traceability is essential during development, as it also supports the evidence required for regulatory submissions, audits, and post-market cybersecurity reporting.
Enhancing Vulnerability Impact Assessment
Cybersecurity response has become a time-sensitive decision-making challenge. When a vulnerability is disclosed or exploited, organizations must rapidly determine which products, components, configurations, releases, and clinical use cases are affected, in order to support regulatory reporting and remediation decisions. Fragmented lifecycle data can significantly slow down this process, as teams may need to reconcile information from multiple sources, including requirements systems, test repositories, software composition tools, product records, and vulnerability-management platforms. A connected lifecycle approach enables teams to assess impact more quickly, document their decisions, and maintain auditable evidence of their response.
Integrating Software Composition with Lifecycle Management
A Software Bill of Materials (SBOM) provides valuable visibility into software composition, but its value is greatly enhanced when connected to engineering, quality, risk, and release information. MedTech organizations must link software components to the products and releases in which they are used, monitor these components for emerging vulnerabilities, understand potential impact, and drive controlled remediation when necessary. This creates a continuous process, rather than a one-time documentation exercise, enabling teams to identify, assess, mitigate, verify, release, and monitor vulnerabilities. By maintaining connections between vulnerability findings and requirements, risks, tests, and releases, teams can manage post-market updates more consistently across products and variants.
